New patent for APGDI drug MYRBETRIQ

March 10, 2021 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for MYRBETRIQ Myrbetriq is a drug marketed by Apgdi and is included in one NDA. It is available from three suppliers. There are eight patents protecting…

The post New patent for APGDI drug MYRBETRIQ appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.